The Story and Science Behind the "Mini-brain"
How iPSC-derived 3D organoids and high-throughput histology opens a new door to personalized medicine development and testing.
Simon Plummer |
A few years ago, we had successfully developed technology for high-throughput histology of 3D organoids. Meanwhile, Thomas Hartung at John Hopkins University had been working on "mini-brain" technology derived from iPS cells. After initial discussions at a meeting of the Society of Toxicology in 2016, we quickly recognized that working together could be a great opporunity. We could better demonstrate the utility of our technology, while Thomas could further explore the potential of the mini-brain model.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!